Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Post by aebestaceyon Jul 19, 2018 3:36pm
124 Views
Post# 28340721

insider selling??? where????

insider selling??? where????

Insider Filings

Latest 10 SEDI filings for HUGE within the last 6 months
Amended Filing
As of 11:59pm ET July 18th, 2018
Filing
Date		 Transaction
Date		 Insider Name Ownership
Type		 Securities Nature of transaction Volume or Value Price
Jun 21/18 Jun 12/18 Klacar, Vladimir Direct Ownership Options 50 - Grant of options 3,000,000  
Jun 13/18 Jun 12/18 Goldberg, Gerald Direct Ownership Options 50 - Grant of options 3,000,000 $0.090
Jun 13/18 Jun 12/18 Carroll, Donal Direct Ownership Options 50 - Grant of options 3,000,000 $0.090
Jun 13/18 May 28/18 Goldberg, Gerald Direct Ownership Options 00 - Opening Balance-Initial SEDI Report    
Jun 21/18 May 24/18 Klacar, Vladimir Direct Ownership Options 00 - Opening Balance-Initial SEDI Report    
Jun 13/18 May 24/18 Carroll, Donal Direct Ownership Options 00 - Opening Balance-Initial SEDI Report    
May 31/18 May 24/18 Durkacz, Anthony John Direct Ownership Warrants Warrants 11 - Acquisition carried out privately 40,000,000 $0.022
May 31/18 May 24/18 Durkacz, Anthony John Direct Ownership Warrants Warrants 00 - Opening Balance-Initial SEDI Report    
May 31/18 May 24/18 Durkacz, Anthony John Indirect Ownership Multiple Voting Shares Class A 10 - Acquisition in the public market 5,000  
May 31/18 May 24/18 Durkacz, Anthony John

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities